Human Plus Labs Ltd

	Page
Balance Sheet	1—2
Notes to the Financial Statements	3—5

Registered number: 16408239

		31 December 2025
	Notes	£	£
CURRENT ASSETS
Debtors	4	11,607

		11,607
Creditors: Amounts Falling Due Within One Year	5	(46,629 )

NET CURRENT ASSETS (LIABILITIES)			(35,022 )

TOTAL ASSETS LESS CURRENT LIABILITIES			(35,022 )

NET LIABILITIES			(35,022 )

CAPITAL AND RESERVES
Called up share capital			100
Profit and Loss Account			(35,122 )

SHAREHOLDERS' FUNDS			(35,022)

Page 1

Page 2

Human Plus Labs Ltd

Balance Sheet (continued)

As At 31 December 2025

For the period ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.

On behalf of the board

Mr Sean Connell

Director

15 October 2026

The notes on pages 3 to 5 form part of these financial statements.

1. General Information

Human Plus Labs Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 16408239 . The registered office is Bonding Warehouse, Terry Avenue, York, North Yorkshire, England, YO1 6FA.

2. Accounting Policies

2.1. Basis of Preparation of Financial Statements

The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

2.2. Going Concern Disclosure

The directors believe the company to be a going concern and will continue to give their support to the company over the next 12 months

2.3. Turnover

Turnover is measured at the fair value of the consideration received or receivable, net of value added taxes. Turnover includes revenue earned from the provision of services and is recognised at the point of invoice. If the provision of services spans the financial year end, it is measured by reviewing the actual services performed against the total services to be provided and is only recognised if it can be estimated reliably.

2.4. Financial Instruments

Financial assets and financial liabilities are recognised in the balance sheet when the company becomes a party to the contractual provisions of the instrument.

Trade debtors and creditors are classified as basic financial instruments and are recognised at transaction price less any impairment. A provision is established when there is objective evidence that the company will not be able to collect all amounts due.

Other debtors and creditors are measured at amortised cost using the effective interest rate method.

Cash and cash equivalents are classified as basic financial instruments and comprise cash in hand and at bank and bank overdrafts.

Financial liabilities and equity instruments issued by the company are classified in accordance with the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Equity instruments issued by the company are recorded at the proceeds received.

Page 3

Page 4

Human Plus Labs Ltd

Notes to the Financial Statements (continued)

For the Period 25 April 2025 to 31 December 2025

2.5. Taxation

The taxation expense represents the sum of the tax currently payable and deferred tax. Current or deferred tax for the year is recognised in profit or loss, except when they related to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax is also recognised in other comprehensive income or directly in equity respectively.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the profit and loss account because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.

Deferred tax

Deferred tax has not been recognised as it is not material to the financial statements. The director will review

this annually.

3. Average Number of Employees

Average number of employees, including directors, during the period was: 1

4. Debtors

	31 December 2025
	£
Due within one year
Amounts owed by group undertakings	11,607

5. Creditors: Amounts Falling Due Within One Year

	31 December 2025
	£
Amounts owed to group undertakings	44,266
Other creditors	2,363

	46,629

6. Related Party Transactions

The amount due from group undertaking at the period end was £11,607.

The amount due to group undertaking at the period end was £44,266.

Page 4

Page 5

Human Plus Labs Ltd

Notes to the Financial Statements (continued)

For the Period 25 April 2025 to 31 December 2025

7. Ultimate Controlling Party

The company's ultimate controlling party is Super Assembly Ltd by virtue of ownership of 100% of the issued share capital in the company as of 11 September 2025. Super Assembly Ltd is incorporated in England and Wales. The registered office of Super Assembly Ltd is: Bonding Warehouse, Terry Avenue, York, United Kingdom, YO1 6FA.

Page 5